These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

838 related items for PubMed ID: 17398176

  • 1. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome.
    Sukhija R, Fahdi I, Garza L, Fink L, Scott M, Aude W, Pacheco R, Bursac Z, Grant A, Mehta JL.
    Am J Cardiol; 2007 Apr 01; 99(7):879-84. PubMed ID: 17398176
    [Abstract] [Full Text] [Related]

  • 2. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?
    Gotsman I, Stabholz A, Planer D, Pugatsch T, Lapidus L, Novikov Y, Masrawa S, Soskolne A, Lotan C.
    Isr Med Assoc J; 2008 Jul 01; 10(7):494-8. PubMed ID: 18751625
    [Abstract] [Full Text] [Related]

  • 3. Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain: The PROMISE Trial Results.
    Ferencik M, Mayrhofer T, Lu MT, Bittner DO, Emami H, Puchner SB, Meyersohn NM, Ivanov AV, Adami EC, Voora D, Ginsburg GS, Januzzi JL, Douglas PS, Hoffmann U.
    JACC Cardiovasc Imaging; 2022 Aug 01; 15(8):1427-1438. PubMed ID: 35926901
    [Abstract] [Full Text] [Related]

  • 4. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
    Pan HC, Sheu WH, Lee WJ, Lee WL, Liao YC, Wang KY, Lee IT, Wang JS, Liang KW.
    Clin Chim Acta; 2015 May 20; 445():93-100. PubMed ID: 25818243
    [Abstract] [Full Text] [Related]

  • 5. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis.
    Caixeta AM, Brito FS, Costa MA, Serrano CV, Petriz JL, Da Luz PL.
    Catheter Cardiovasc Interv; 2007 Mar 01; 69(4):500-7. PubMed ID: 17285569
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines.
    Kim JY, Choi EY, Mun HS, Min PK, Yoon YW, Lee BK, Hong BK, Rim SJ, Kwon HM.
    Cardiovasc Diabetol; 2013 Oct 02; 12():140. PubMed ID: 24088407
    [Abstract] [Full Text] [Related]

  • 7. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
    Koc M, Karaarslan O, Abali G, Batur MK.
    Tex Heart Inst J; 2010 Oct 02; 37(1):42-8. PubMed ID: 20200626
    [Abstract] [Full Text] [Related]

  • 8. Perivascular fat attenuation index and high-risk plaque features evaluated by coronary CT angiography: relationship with serum inflammatory marker level.
    Dai X, Deng J, Yu M, Lu Z, Shen C, Zhang J.
    Int J Cardiovasc Imaging; 2020 Apr 02; 36(4):723-730. PubMed ID: 31907683
    [Abstract] [Full Text] [Related]

  • 9. Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease.
    Sentürk T, Cordan J, Baran I, Ozdemir B, Güllülü S, Aydinlar A, Göral G.
    Acta Cardiol; 2007 Apr 02; 62(2):135-41. PubMed ID: 17536601
    [Abstract] [Full Text] [Related]

  • 10. High-sensitivity troponin T level and angiographic severity of coronary artery disease.
    Ndrepepa G, Braun S, Schulz S, Mehilli J, Schömig A, Kastrati A.
    Am J Cardiol; 2011 Sep 01; 108(5):639-43. PubMed ID: 21676369
    [Abstract] [Full Text] [Related]

  • 11. Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention.
    Liu Y, Jia SD, Yao Y, Tang XF, Xu N, Jiang L, Gao Z, Chen J, Yang YJ, Gao RL, Xu B, Yuan JQ.
    J Cardiol; 2020 Jan 01; 75(1):60-65. PubMed ID: 31416781
    [Abstract] [Full Text] [Related]

  • 12. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, Pepine CJ, Sharaf B, Bairey Merz CN, Sopko G, Olson MB, Reis SE, National Heart, Lung, and Blood Institute.
    Circulation; 2004 Feb 17; 109(6):726-32. PubMed ID: 14970107
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease.
    Arroyo-Espliguero R, Avanzas P, Quiles J, Kaski JC.
    Atherosclerosis; 2009 May 17; 204(1):239-43. PubMed ID: 18823889
    [Abstract] [Full Text] [Related]

  • 14. C-reactive protein elevation and disease activity in patients with coronary artery disease.
    Arroyo-Espliguero R, Avanzas P, Cosín-Sales J, Aldama G, Pizzi C, Kaski JC.
    Eur Heart J; 2004 Mar 17; 25(5):401-8. PubMed ID: 15033252
    [Abstract] [Full Text] [Related]

  • 15. Correlation of concentrations of high-sensitivity troponin T and high-sensitivity C-reactive protein with plaque progression as measured by CT coronary angiography.
    Seifarth H, Schlett CL, Lehman SJ, Bamberg F, Donnelly P, Januzzi JL, Koenig W, Truong QA, Hoffmann U.
    J Cardiovasc Comput Tomogr; 2014 Mar 17; 8(6):452-8. PubMed ID: 25467832
    [Abstract] [Full Text] [Related]

  • 16. Association between interleukin-6 and the risk of cardiac events measured by coronary computed tomography angiography.
    Zhao L, Wang X, Yang Y.
    Int J Cardiovasc Imaging; 2017 Aug 17; 33(8):1237-1244. PubMed ID: 28233119
    [Abstract] [Full Text] [Related]

  • 17. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy.
    Ishizu T, Seo Y, Machino T, Kawamura R, Kimura T, Murakoshi N, Sato A, Takeyasu N, Watanabe S, Aonuma K.
    Atherosclerosis; 2011 May 17; 216(1):120-4. PubMed ID: 21353222
    [Abstract] [Full Text] [Related]

  • 18. Comparison of inflammatory markers for the prediction of neointimal hyperplasia after drug-eluting stent implantation.
    Kang WC, Il Moon C, Lee K, Han SH, Suh SY, Moon J, Shin MS, Ahn T, Shin EK.
    Coron Artery Dis; 2011 Dec 17; 22(8):526-32. PubMed ID: 21909023
    [Abstract] [Full Text] [Related]

  • 19. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C, Sudre A, Lemesle G, Maréchaux S, Broucqsault D, Hennache B, Bauters C, Lablanche JM.
    Cardiovasc Revasc Med; 2009 Dec 17; 10(3):144-50. PubMed ID: 19595394
    [Abstract] [Full Text] [Related]

  • 20. Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography.
    Othman A, Saely CH, Muendlein A, Vonbank A, Drexel H, von Eckardstein A, Hornemann T.
    Atherosclerosis; 2015 May 17; 240(1):216-21. PubMed ID: 25801014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.